Spatial omics and multiplexed imaging to explore cancer biology
Understanding intratumoral heterogeneity—the molecular variation among cells within a
tumor—promises to address outstanding questions in cancer biology and improve the …
tumor—promises to address outstanding questions in cancer biology and improve the …
Optimized jumping on the mit cheetah 3 robot
This paper presents a novel methodology for implementing optimized jumping behavior on
quadruped robots. Our method includes efficient trajectory optimization, precise high-…
quadruped robots. Our method includes efficient trajectory optimization, precise high-…
[HTML][HTML] Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: Fundamentals Of Care for UveitiS (FOCUS) initiative
Topic An international, expert-led consensus initiative to develop systematic, evidence-based
recommendations for the treatment of noninfectious uveitis in the era of biologics. Clinical …
recommendations for the treatment of noninfectious uveitis in the era of biologics. Clinical …
[HTML][HTML] Brolucizumab: evolution through preclinical and clinical studies and the implications for the management of neovascular age-related macular degeneration
QD Nguyen, A Das, DV Do, PU Dugel, A Gomes… - Ophthalmology, 2020 - Elsevier
Improving or maintaining visual acuity is the main goal for the treatment of neovascular age-related
macular degeneration (nAMD). Current nAMD standard of care dictates frequent …
macular degeneration (nAMD). Current nAMD standard of care dictates frequent …
Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration
OBJECTIVE: Two similarly designed, phase-3 studies (VEGF Trap-Eye: Investigation of
Efficacy and Safety in Wet AMD [VIEW 1, VIEW 2]) of neovascular age-related macular …
Efficacy and Safety in Wet AMD [VIEW 1, VIEW 2]) of neovascular age-related macular …
Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE
QD Nguyen, DM Brown, DM Marcus, DS Boyer, S Patel… - Ophthalmology, 2012 - Elsevier
PURPOSE: To evaluate the efficacy and safety of intravitreal ranibizumab in diabetic
macular edema (DME) patients. DESIGN: Two parallel, methodologically identical, phase III, …
macular edema (DME) patients. DESIGN: Two parallel, methodologically identical, phase III, …
Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis
…, NS Falk, DS Chu, D Callanan, QD Nguyen… - Science translational …, 2010 - science.org
Interleukin-17A (IL-17A) is elaborated by the T helper 17 (T H 17) subset of T H cells and
exhibits potent proinflammatory properties in animal models of autoimmunity, including collagen…
exhibits potent proinflammatory properties in animal models of autoimmunity, including collagen…
[HTML][HTML] Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE
DM Brown, QD Nguyen, DM Marcus, DS Boyer, S Patel… - Ophthalmology, 2013 - Elsevier
… Brown MD 1 § , Quan Dong Nguyen MD, MSc 2 § , Dennis M. Marcus MD 3 , David S. Boyer
MD 4 , Sunil … QD Nguyen, DM Brown, DM Marcus, et al., RISE and RIDE Research Group …
MD 4 , Sunil … QD Nguyen, DM Brown, DM Marcus, et al., RISE and RIDE Research Group …
Intravitreal aflibercept for diabetic macular edema
…, PK Kaiser, H Terasaki, DM Marcus, QD Nguyen… - Ophthalmology, 2014 - Elsevier
Purpose A head-to-head comparison was performed between vascular endothelial growth
factor blockade and laser for treatment of diabetic macular edema (DME). Design Two …
factor blockade and laser for treatment of diabetic macular edema (DME). Design Two …
Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six–week results of the VIEW studies
Purpose To determine efficacy and safety of intravitreal aflibercept in patients with neovascular
age-related macular degeneration (AMD) during a second year of variable dosing after a …
age-related macular degeneration (AMD) during a second year of variable dosing after a …
